IRIS
PINI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.417
EU - Europa 8.157
AS - Asia 3.475
SA - Sud America 585
AF - Africa 61
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 11
Totale 20.722
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.328
GB - Regno Unito 1.906
RU - Federazione Russa 1.621
CN - Cina 1.411
IT - Italia 1.262
SG - Singapore 1.010
IE - Irlanda 970
SE - Svezia 612
UA - Ucraina 522
BR - Brasile 481
DE - Germania 470
FR - Francia 275
HK - Hong Kong 268
KR - Corea 235
FI - Finlandia 188
VN - Vietnam 188
IN - India 100
ES - Italia 77
BE - Belgio 59
CA - Canada 51
PL - Polonia 48
BD - Bangladesh 44
AR - Argentina 40
NL - Olanda 37
TR - Turchia 34
AT - Austria 25
IR - Iran 24
JP - Giappone 24
PK - Pakistan 24
CZ - Repubblica Ceca 22
MX - Messico 20
ZA - Sudafrica 20
AU - Australia 13
VE - Venezuela 13
CL - Cile 12
CI - Costa d'Avorio 11
CO - Colombia 11
EC - Ecuador 11
EU - Europa 11
PH - Filippine 11
IQ - Iraq 10
AZ - Azerbaigian 9
CH - Svizzera 9
IL - Israele 9
UZ - Uzbekistan 9
AE - Emirati Arabi Uniti 8
JO - Giordania 8
LT - Lituania 8
PE - Perù 8
RO - Romania 8
EG - Egitto 7
DK - Danimarca 6
ID - Indonesia 6
KE - Kenya 6
KZ - Kazakistan 6
TW - Taiwan 6
BY - Bielorussia 5
EE - Estonia 5
MA - Marocco 5
PY - Paraguay 5
SA - Arabia Saudita 5
DZ - Algeria 4
LA - Repubblica Popolare Democratica del Laos 4
AM - Armenia 3
BB - Barbados 3
BG - Bulgaria 3
CR - Costa Rica 3
JM - Giamaica 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
OM - Oman 3
RS - Serbia 3
TN - Tunisia 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GR - Grecia 2
KG - Kirghizistan 2
NP - Nepal 2
PA - Panama 2
PT - Portogallo 2
TH - Thailandia 2
BN - Brunei Darussalam 1
CM - Camerun 1
CY - Cipro 1
GD - Grenada 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
LB - Libano 1
LK - Sri Lanka 1
MM - Myanmar 1
MT - Malta 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
PS - Palestinian Territory 1
Totale 20.713
Salva come PNG Salva come JPEG
Città #
Southend 1.750
Dallas 1.040
Dublin 959
Fairfield 778
Ashburn 624
Singapore 569
Chandler 554
Siena 482
Moscow 461
Jacksonville 425
Woodbridge 400
Santa Clara 399
Beijing 380
Ann Arbor 349
Seattle 325
Wilmington 321
Houston 301
Menlo Park 260
Hong Kong 259
Hefei 248
Cambridge 246
Seoul 233
Princeton 171
Nanjing 133
Los Angeles 131
New York 121
Munich 94
Milan 92
Dong Ket 87
Boardman 84
Florence 70
Helsinki 67
San Mateo 67
Málaga 60
Rome 59
Shanghai 57
Nanchang 56
Buffalo 52
San Diego 50
São Paulo 50
The Dalles 50
Council Bluffs 44
Dearborn 42
Fremont 42
Shenyang 41
Bengaluru 37
Brussels 37
Hebei 34
Turku 34
Chicago 29
Redwood City 29
London 28
Ho Chi Minh City 27
Hanoi 24
Kunming 24
Redondo Beach 24
Tianjin 24
Warsaw 24
Washington 24
Brooklyn 23
Columbus 23
Toronto 23
Bagno a Ripoli 21
Changsha 20
Stockholm 20
Brno 19
Nuremberg 19
Phoenix 19
Düsseldorf 18
Johannesburg 18
Jiaxing 17
San Francisco 17
Atlanta 16
Denver 16
Montreal 16
Ningbo 16
Tokyo 16
Vienna 16
Belo Horizonte 15
Frankfurt am Main 15
Izmir 15
Zhengzhou 15
Dhaka 14
Gdansk 14
Guangzhou 14
Rio de Janeiro 14
Chennai 13
Hangzhou 13
Kansas City 13
Lappeenranta 13
Amsterdam 12
Jinan 12
Orem 12
Abidjan 11
Lancaster 11
Poplar 11
Arezzo 10
Baku 9
Boston 9
Brasília 9
Totale 14.109
Salva come PNG Salva come JPEG
Nome #
Near-infrared quantum dots labelled with a tumor selective tetrabranched peptide for in vivo imaging 351
Insights into the role of sulfated glycans in cancer cell adhesion and migration through use of branched peptide probe 342
The GAG-specific branched peptide NT4 reduces angiogenesis and invasiveness of tumor cells 340
Investigations into the killing activity of an antimicrobial peptide active against extensively antibiotic-resistant K. pneumoniae and P. aeruginosa 321
Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drug 304
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo. 304
Heparan sulfate proteoglycans can promote opposite effects on adhesion and directional migration of different cancer cells 299
Cancer selectivity of tetrabranched neurotensin peptides is generated by simultaneous binding to sulfated glycosaminoglycans and protein receptors. 288
An antimicrobial molecule mitigates signs of sepsis in vivo and eradicates infections from lung tissue 285
Efficacy and toxicity of the antimicrobial peptide M33 produced with different counter-ions 280
A new NT4 peptide-based drug delivery system for cancer treatment 279
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo 278
Neurotensin branched peptide as a tumor-targeting agent for human bladder cancer 278
The proteome speciation of an immortalized cystic fibrosis cell line: New perspectives on the pathophysiology of the disease 272
Unraveling Heparan Sulfate Proteoglycan Binding Motif for Cancer Cell Selectivity 272
A novel phage-library-selected peptide inhibits human TNF-α binding to its receptors 263
In vitro and in vivo efficacy, toxicity, bio-distribution and resistance selection of a novel antibacterial drug candidate 258
Coupling to a cancer-selective heparan-sulfate-targeted branched peptide can by-pass breast cancer cell resistance to methotrexate 257
Isomerization of an Antimicrobial Peptide Broadens Antimicrobial Spectrum to Gram-Positive Bacterial Pathogens 257
Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification. 256
Tumor imaging with tetrabranched neurotensin 251
Antimicrobial peptide-loaded nanoparticles as inhalation therapy for Pseudomonas aeruginosa infections 246
Supramolecular aggregates as drug carriers on cell expressing receptors for branched Neurotensin 245
Site-specific pegylation of an antimicrobial peptide increases resistance to Pseudomonas aeruginosa elastase 245
Antibacterial and anti-inflammatory activity of an antimicrobial peptide synthesized with D amino acids 245
Antimicrobial activity of levofloxacin - M33 peptide conjugation or combination 244
Analysis of the utility of a rapid vesicle isolation method for clinical strains of Pseudomonas aeruginosa 243
A branched peptide mimotope of the nicotinic receptor binding site is a potent synthetic antidote against the snake neurotoxin alpha-bungarotoxin 242
Branched peptides as bioactive molecules for drug design 239
Large-scale screening of organ specific autoantibodies in patients with autoimmune thyroid diseases 238
Branched Neurotensin For Tumor Targeting 232
Antibacterial peptides and analogues thereof 231
Branched peptides for tumor diagnosis and therapy 229
Modular Branched Neurotensin Peptides for Tumor Target Tracing and Receptor-Mediated Therapy: A Proof-of-Concept 226
Bioactive peptides from libraries 225
Antibacterial and Anti-Inflammatory Activity of Branched Peptides Derived from Natural Host Defense Sequences 223
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 216
Biochemical filtering of a protein-protein docking simulation identifies the structure of a complex between a recombinant antibody fragment and alpha-bungarotoxin 215
Branched peptides as targeting agents for tumor imaging and therapy 215
D-Amino acids incorporation in the frog skin-derived peptide esculentin-1a(1-21)NH2 is beneficial for its multiple functions 210
Dendrimeric peptide inhibitors of anthrax lethal and edema factors 208
Mimicking the nicotinic receptor binding site by a single chain Fv selected by competitive panning from a synthetic phage library 207
Antimicrobial peptide, branched forms thereof, and their use in the treatment of bacterial infections 207
Synthetic peptides in the form of dendrimers become resistant to protease activity 206
Antimicrobial peptides active in in vitro models of endodontic bacterial infections modulate inflammation in human cardiac fibroblasts 205
Branched multimeric peptides for tumor diagnosis and therapy 205
Esculentin-1a-derived peptides promote clearance of pseudomonas aeruginosa internalized in bronchial cells of cystic fibrosis patients and lung cell migration: Biochemical properties and a plausible mode of action 204
Branched Neurotensin peptides for tumor personalized therapy 203
Synthesis and biological activity of stable branched neurotensin peptides for tumor targeting 199
Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens 199
Targeting different LRP receptors and sulfated proteoglycan by branched neurotensin provide high cancer selectivity 198
Branched neurotensin for tumor targeting 197
The development of antimicrobial peptides as new antibacterial drugs 197
Turning nonspecific cytotoxic drugs into tumor-selective agents via conjugation to branched peptides. 194
Endocytosis and trafficking of heparan sulfate proteoglycans in triple-negative breast cancer cells unraveled with a polycationic peptide 194
Design and in vitro evaluation of branched peptide conjugates:turning nonspecific cytotoxic drugs into tumor-selective agents 193
ANTICORPI E PEPTIDI -I farmaci del XXI secolo- 190
The antimicrobial peptide M33. An example of drug development 189
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 187
Molecular basis of branched peptides resistance to enzyme proteolysis 187
Mimotopes of the nicotinic receptor binding site selected by a combinatorial peptide library 185
Antimicrobial activity of two novel antimicrobial peptides AA139 and SET-M33 against clinically and genotypically diverse Klebsiella pneumoniae isolates with differing antibiotic resistance profiles 185
Biochemical characterization and strong in vivo activity of a novel antimicrobial peptide specific for gram-negative bacteria 182
Tumor selective targeting by branched peptides 179
Neurotensin-derived branched peptides and uses thereof 177
Dendrimeric peptide inhibitors of anthrax lethal and edema factor 167
Phage display and colony filter screening for high-throughput selection of antibody libraries 167
NMR study of the secondary structure and biopharmaceutical formulation of an active branched antimicrobial peptide 167
Branched peptides as therapeutics 165
Characterization of the branched antimicrobial peptide M6 by analyzing its mechanism of action and in vivo toxicity. 164
Synthetic antidotes against snake neurotoxins 163
COMPOSTI ANTI TNF-ALPHA E LORO USI 162
The antimicrobial peptide M33. An example of drug development 156
Target Selective Drug Delivery through Liposome Labeled with Oligobranched Neurotensin Peptides 150
Multiple Antigen Peptides (MAP) as antidotes against snake neurotoxin intoxication 149
Targeting by affinity–matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform 149
Esculentin(1-21), an amphibian skin membrane-active peptide with potent activity on both planktonic and biofilm cells of the bacterial pathogen Pseudomonas aeruginosa 149
Oligo-branched peptides for tumor targeting: From magic bullets to magic forks 149
Solubility improvement of an anthrax toxin peptide inhibitor by rational aminoacid randomization 147
Tumor imaging with tetrabranched neurotensin 147
Branched oncolytic peptides target HSPGs, inhibit metastasis, and trigger the release of molecular determinants of immunogenic cell death in pancreatic cancer 146
Branched neurotensin peptides for tumor targeting 145
Strategies for the construction and use of peptide and antibody libraries displayed on phages. 143
Peptide sequences, their branched form and use thereof for antimicrobial applications 142
Stable peptide inhibitors prevent binding of lethal and oedema factors to protective antigen and neutralize anthrax toxin in vivo 142
Dendrimeric peptides for tumor targeting 138
Screening of organ-specific autoantibodies in a large cohort of patients with autoimmune thyroid diseases. 138
Phage display of antibody fragments 134
Safety evaluations of a synthetic antimicrobial peptide administered intravenously in rats and dogs 131
Synthetic peptides in the form of dendrimers can become resistant to protease activity 131
Rational design and molecular diversity for the construction of anti-alpha-bungarotoxin antidotes with high affinity and in vivo efficiency 129
Synthetic inhibitors of anthrax lethal toxin 128
The tardigrade damage suppressor protein modulates transcription factor and DNA repair genes in human cells treated with hydroxyl radicals and UV-C 127
In Vivo Efficacy and Toxicity of an Antimicrobial Peptide in a Model of Endotoxin-Induced Pulmonary Inflammation 125
In vitro inhalation cytotoxicity testing of therapeutic nanosystems for pulmonary infection 125
Antimicrobial Peptides towards Clinical Application-A Long History to Be Concluded 124
Inhalable Polymeric Nanoparticles for Pulmonary Delivery of Antimicrobial Peptide SET-M33: antibacterial activity and toxicity in vitro and in vivo 121
Targeting heparan sulfate proteoglycans as an effective strategy for inhibiting cancer cell migration and invasiveness compared to heparin 120
Pulmonary Safety Profile of Esc Peptides and Esc-Peptide-Loaded Poly(lactide-co-glycolide) Nanoparticles: A Promising Therapeutic Approach for Local Treatment of Lung Infectious Diseases 115
Turning Traditional Cytotoxic Drugs Into Tumour-selective Agents 115
Totale 20.291
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.295
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.295
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.736 0 0 0 0 0 330 226 307 205 310 152 206
2021/20221.476 87 157 96 157 93 62 60 78 58 165 171 292
2022/20232.050 114 207 253 279 221 384 50 161 170 85 87 39
2023/20241.572 51 49 130 77 69 440 550 34 8 35 20 109
2024/20253.193 72 140 358 185 390 181 126 200 241 119 331 850
2025/20264.915 565 1.040 846 930 1.470 64 0 0 0 0 0 0
Totale 20.991